Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 La Crosse virus small genome mRNA is made in the cytoplasm.

Literature DB >> 3701924

La Crosse virus small genome mRNA is made in the cytoplasm.

Abstract

The cellular site of La Crosse virus S genome mRNA synthesis was examined by pulse-labeling infected cells for various times and determining the amount of labeled S mRNA in both the cytoplasmic and nuclear fractions. With pulse times as short as 3 min, La Crosse virus S genome transcription was found to be localized in the cytoplasm.

Entities: Species

Mesh：

Substances：
RNA, Messenger
RNA, Viral

Year: 1986 PMID： 3701924 PMCID： PMC252955

Source DB: PubMed Journal: J Virol ISSN： 0022-538X Impact factor: 5.103

10 in total

Review 1. Bunyaviridae: recent biochemical developments.

Authors: J F Obijeski; F A Murphy
Journal: J Gen Virol Date: 1977-10 Impact factor: 3.891

Review 2. Bunyaviridae.

Authors: D H Bishop; C H Calisher; J Casals; M P Chumakov; S Y Gaidamovich; C Hannoun; D K Lvov; I D Marshall; N Oker-Blom; R F Pettersson; J S Porterfield; P K Russell; R E Shope; E G Westaway
Journal: Intervirology Date: 1980 Impact factor: 1.763

3. California encephalitis virus: some biological and biochemical properties.

Authors: N Goldman; I Presser; T Sreevalsan
Journal: Virology Date: 1977-01 Impact factor: 3.616

Review 4. Priming of influenza viral RNA transcription by capped heterologous RNAs.

Authors: R M Krug
Journal: Curr Top Microbiol Immunol Date: 1981 Impact factor: 4.291

Review 5. The gene structure and replication of influenza virus.

Authors: R A Lamb; P W Choppin
Journal: Annu Rev Biochem Date: 1983 Impact factor: 23.643

6. Nonviral heterogeneous sequences are present at the 5' ends of one species of snowshoe hare bunyavirus S complementary RNA.

Authors: D H Bishop; M E Gay; Y Matsuoko
Journal: Nucleic Acids Res Date: 1983-09-24 Impact factor: 16.971

7. La Crosse virions contain a primer-stimulated RNA polymerase and a methylated cap-dependent endonuclease.

Authors: J L Patterson; B Holloway; D Kolakofsky
Journal: J Virol Date: 1984-10 Impact factor: 5.103

8. Influenza virus, an RNA virus, synthesizes its messenger RNA in the nucleus of infected cells.

Authors: C Herz; E Stavnezer; R Krug; T Gurney
Journal: Cell Date: 1981-11 Impact factor: 41.582

9. Characterization of La Crosse virus small-genome transcripts.

Authors: J L Patterson; D Kolakofsky
Journal: J Virol Date: 1984-03 Impact factor: 5.103

10. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease.

Authors: J M Chirgwin; A E Przybyla; R J MacDonald; W J Rutter
Journal: Biochemistry Date: 1979-11-27 Impact factor: 3.162

10 in total

18 in total

9. Inhibition of cap (m7GpppXm)-dependent endonuclease of influenza virus by 4-substituted 2,4-dioxobutanoic acid compounds.

Authors: J Tomassini; H Selnick; M E Davies; M E Armstrong; J Baldwin; M Bourgeois; J Hastings; D Hazuda; J Lewis; W McClements
Journal: Antimicrob Agents Chemother Date: 1994-12 Impact factor: 5.191

10. Generation and analysis of recombinant Bunyamwera orthobunyaviruses expressing V5 epitope-tagged L proteins.

Authors: Xiaohong Shi; Richard M Elliott
Journal: J Gen Virol Date: 2009-02 Impact factor: 3.891

La Crosse virus small genome mRNA is made in the cytoplasm.

Review 1. Bunyaviridae: recent biochemical developments.

Review 2. Bunyaviridae.

3. California encephalitis virus: some biological and biochemical properties.

Review 4. Priming of influenza viral RNA transcription by capped heterologous RNAs.

Review 5. The gene structure and replication of influenza virus.

6. Nonviral heterogeneous sequences are present at the 5' ends of one species of snowshoe hare bunyavirus S complementary RNA.

7. La Crosse virions contain a primer-stimulated RNA polymerase and a methylated cap-dependent endonuclease.

8. Influenza virus, an RNA virus, synthesizes its messenger RNA in the nucleus of infected cells.

9. Characterization of La Crosse virus small-genome transcripts.

10. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease.

1. Anti-mRNAs in La Crosse bunyavirus-infected cells.

2. Expression of functional Bunyamwera virus L protein by recombinant vaccinia viruses.

3. The translational requirement for complete La Crosse virus mRNA synthesis is cell-type dependent.

4. Anti-influenza virus activities of 4-substituted 2,4-dioxobutanoic acid inhibitors.

5. A novel antiviral agent which inhibits the endonuclease of influenza viruses.

6. Vaccines and me.

7. Hantavirus nucleocapsid protein is expressed as a membrane-associated protein in the perinuclear region.

8. Unusual transcripts in La Crosse virus-infected cells and the site for nucleocapsid assembly.

9. Inhibition of cap (m7GpppXm)-dependent endonuclease of influenza virus by 4-substituted 2,4-dioxobutanoic acid compounds.

10. Generation and analysis of recombinant Bunyamwera orthobunyaviruses expressing V5 epitope-tagged L proteins.